用于癌症治疗的表观遗传抑制剂
Hongchao Yuan1, Yuanjun Lu1, Yibin Feng1
1School of Chinese Medicine, The University of Hong Kong, Pokfulam, Hong Kong.
International review of cell and molecular biology
|February 15, 2024
概括
表观遗传调节剂影响癌症的进展和化学抵抗. 用表观遗传药物向这些异常调节剂为癌症治疗提供了一个有希望的策略,目前正在研究新型抑制剂.
科学领域:
- 分子生物学分子生物学
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 表观遗传学涉及可遗传,可逆的修改影响基因表达而不改变DNA序列.
- 异常的表观遗传调节剂与癌症进展有关,影响瘤细胞和瘤微环境 (TME).
- 表观遗传调节者显示出作为预测临床结果和化学抵抗的生物标志物的潜力.
研究的目的:
- 审查表观遗传抑制剂在癌症治疗中的应用和最新进展.
- 探索针对癌症治疗的放松监管表观遗传调节者的潜力.
- 讨论表观遗传药物开发的未来前景.
主要方法:
- 对癌症治疗中的表观遗传抑制剂的当前文献的综述.
- 对表观遗传药物的临床前和临床试验数据的分析.
- 探索天然化合物和合成分子作为表观遗传抑制剂.
主要成果:
- 目前的表观遗传药物在临床前和临床癌症研究中显示出有希望的疗效.
- 向表观遗传调节器是癌症治疗的有力的策略.
- 很少有表观遗传药物得到FDA的批准,这凸显了需要进一步的研究和开发.
结论:
- 表观遗传抑制剂代表了癌症的重要治疗策略.
- 持续的研究对于开发新型和有效的表观遗传药物至关重要.
- 该领域对改善癌症治疗结果和克服抗化学药性有前途.
相关概念视频
Epigenetic Regulation
3.0K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.0K
Eukaryotic Transcription Inhibitors
9.8K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
9.8K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.4K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.4K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K


